Latest filing published 11 Jun 2012 for BG Medicine, Inc., €131k.
Insider track record
No signal scores available.
Pieter Muntendam: trading record in brief
Pieter Muntendam discloses dealings in BG Medicine, Inc. to SEC (Form 4). In total, 6 filings cover trades dated from 9 February 2011 to 8 June 2012.
On the market, this insider has only sold: 3 sales, €148k in total. Outside the open market, there are 1 share grant and 1 option exercise. So far in 2012, the count stands at no purchases and 2 sales.
The record was last updated on 11 June 2012 with an open-market sale (€131k) in BG Medicine, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Pieter Muntendam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,021 shares@ US$5.50Common StockSEC:0001181431-12-035926:0
- 3,965 shares@ US$5.29Common StockSEC:0001181431-12-035926:1
- 100,000 shares@ US$0.90Common StockSEC:0001181431-12-034074:0
- 2,803 shares@ US$0.03Common StockSEC:0001181431-11-048254:0
- 14 shares@ US$6.29Common StockSEC:0001181431-11-048254:1
- 9,680 sharesCommon StockSEC:0001181431-11-009577:0
6 of 6 declarations
